Msc Higia Vassoler

Higia Vassoler, MSc, has a diverse work experience spanning over several years. Higia worked as an Associate Director in Pricing & Market Access at Red Nucleus since March 2022. Prior to that, they served as a Senior Consultant in Pricing & Market Access at RJW&partners from November 2017 to February 2022. Higia also worked as a Global Market Insights & Forecasting specialist in Market Prognosis at IQVIA from October 2013 to October 2017. Before that, they were a Senior Analyst at Datamonitor Healthcare from May 2011 to September 2013, conducting research and generating forecasts. Higia also held roles as a Healthcare Analyst at BMI Research, Fitch Solutions from May 2010 to April 2011, and as an R&D Scientist on a temporary contract at Syngenta from February 2010 to April 2010. Higia started their career as an Analytical Chemist Intern at Sirius Analytical from November 2009 to February 2010. Additionally, they worked as a Research Scientist during their MSc program in Drug Discovery at Cancer Research UK - Spirogen from January 2009 to July 2009, where they published research on DNA-interactive pyrrolo [2, 1-c][1, 4] benzodiazepine (PBD) antitumor agents.

Higia Vassoler holds a PG Certificate in Health Economics from the University of York, which they obtained in the years 2019-2020. Prior to that, they completed their Master of Science (MS) in Drug Discovery at UCL from 2008 to 2009. Their education journey started at the University of Sussex, where they earned a Bachelor of Science (BS) in Chemistry between 2005 and 2008.